From soluble uric acid to sodium urate crystal: immune metabolic inflammation driven by uric acid morphological transformation and mechanism-oriented therapy - PubMed
4 hours ago
- #uric acid
- #NLRP3 inflammasome
- #immune-metabolic inflammation
- Uric acid has complex bidirectional effects on human physiology, influenced by its antioxidant capacity, metabolic regulatory roles, and pro-inflammatory properties.
- The continuum from soluble uric acid (SUA) to amorphous monosodium urate (AMSU) and crystalline monosodium urate (MSU) is explored, with AMSU proposed as a transitional intermediate.
- AMSU may act as a buffering stage between crystallization and inflammatory activation, linking urate phase transitions to immune-metabolic signaling.
- SUA plays physiological roles in maintaining redox homeostasis and regulating metabolism, while hyperuricemia contributes to chronic organ damage via impaired autophagy and metabolic inflammation.
- MSU crystal formation triggers acute inflammatory responses through the TLR-NLRP3 two-signal model, leading to chronic tissue remodeling and progressive pathology.
- The review connects mechanistic insights to therapeutic strategies, advocating for stage-specific and mechanism-oriented interventions.
- An integrated perspective on hyperuricemia-associated diseases is provided, suggesting directions for future targeted therapeutic research.